Sanofi (NASDAQ: SNY) reported Q1 EPS of EUR2.16, EUR0.16 better than the analyst estimate of EUR2.00. Revenue for the quarter came in at EUR10.22 billion versus the consensus estimate of EUR10.3 billion.

Confirms FY23 guidance of business EPS growing low single digit at constant exchange rates

For earnings history and earnings-related data on Sanofi (SNY) click here.